If you want to join our team, please use this link to apply

The post We are hiring! appeared first on Milwaukee Institute for Drug Discovery.

We are thankful to our graduate students Ethan Kowalczyk, Omolola Adedeji, Sharmin Shampa, and Collin Acheampong that were tasked to conduct daily hands-on and class room exercises. The new 51���� chemistry building offered an outstanding laboratory infrastructure to support various aspects of the Re-Charge Stem program curriculum. Many laboratory sections were supervised by Manager Anna Benko, who coordinated with several companies to integrate this program with the local industry. For instance, we had teaching our students to use auto-titrators for water content and was working with our students to develop their resume and shared tips and trick for job interviews. Organic chemistry was another focus of the program. Students performed organic synthesis, analyzed their samples and used several strategies to purify their products. During the course of this section, students learn to handle harmful chemicals and understand the properties of organic compounds in addition to several analytical method for compound characterization. Some of the highlights of the program were site visits at , , , , , and . We like to thank representatives of the companies for their time and dedication to education.

On the last day, companies interviewed our students to potentially fill open laboratory technician positions. Our students were very enthusiastic and showed great diligence and perseverance. We are looking forward to continue this program in 2026 with available funds from the Universities of Wisconsin. For 2027, we are looking for sponsors that will enable us to continue offering this program. Donate .

The post Re-Charge STEM summer program 2025 appeared first on Milwaukee Institute for Drug Discovery.

The post Prof. Yang’s work was highlighted by the Organic Farming Research Foundation appeared first on Milwaukee Institute for Drug Discovery.

The awards will support �����Ի��� during the summer of 2025, enabling them to continue their chemistry graduate work in the laboratories of Profs. and . Mayurika will continue her PhD work focusing on the synthesis of hydrogen peroxide responsive theranostic agents that can be used as targeted cancer therapeutics and bioimaging agents. Maya will continue the synthesis of subtype selective diazepine based ligands for the adrenergic receptor alpha 2B that might lead to novel therapies for anxiety and depression. We are very grateful for the support by that provides funds for both awards. Sterling Pharma Solutions is a small molecule partnership development and manufacturing organization delivering comprehensive small molecule services spanning preclinical development to full commercial manufacturing. The 51���� Chemistry & Biochemistry Department has a strong relationship with Sterling Pharma Solutions in Germantown Wisconsin providing a robust talent pipeline for organic and analytical chemists.

The post Announcement of recipients of the 2025 Sterling Pharma Graduate Student Support Awards appeared first on Milwaukee Institute for Drug Discovery.

Sterling Pharma Solutions is a small molecule partnership development and manufacturing organization delivering comprehensive small molecule services spanning preclinical development to full commercial manufacturing. With locations in the UK, US and Ireland, Sterling Pharma Solutions are purpose-built to handle your needs from discovery through full commercialization. The 51���� Chemistry & Biochemistry Department has a strong relationship with Sterling Pharma Solutions in Germantown, Wisconsin providing a robust talent pipeline for organic and analytical chemists. This year’s Sterling Pharma Conference Travel Awards were selected among abstracts from 51���� graduate students that were submitted to the . The GLRM2025 is hosted this year by the and Local ACS sections in Appleton, Wisconsin from June 4-6. The recipients are Ethan Kowalczyk, Stephen Nkwocha, , , , , , , , and .

The post Announcement of recipients of the 2025 Sterling Pharma Conference Travel Awards appeared first on Milwaukee Institute for Drug Discovery.

The post The Universities of Wisconsin Innovation Grant will support RE-CHARGE, a new program to support the local STEM workforce appeared first on Milwaukee Institute for Drug Discovery.

The post MIDD supports local startup company Simmpyra Pharmaceuticals appeared first on Milwaukee Institute for Drug Discovery.

The post Venture Investors Health Fund supports Sanacor Inc, a local start up company supported by the MIDD appeared first on Milwaukee Institute for Drug Discovery.

The post Sterling donates $25,000 to 51���� Chemistry $ Biochemistry Department and MIDD appeared first on Milwaukee Institute for Drug Discovery.

Nonalcoholic fatty liver disease (NAFLD) has emerged recently as the leading cause of chronic liver disease, affecting ~20% to 30% of the population in United States alone. Currently, there are no clinically approved drugs specifically indicated for the prevention and treatment of NASH. Repurposing of niclosamide might represent a new treatment strategy, which was evaluated by Mr. Pangli by synthesizing new  analogs of niclosamide to improve water solubility, oral bioavailability, and metabolic stability.

The post Randeep Pangli wins MIDD poster award at WISER conference appeared first on Milwaukee Institute for Drug Discovery.